Page last updated: 2024-10-16

anthranilic acid and Osteoporosis

anthranilic acid has been researched along with Osteoporosis in 1 studies

anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"Kynurenines were analysed by HPLC."5.33Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. ( Darlington, LG; Forrest, CM; Mackay, GM; Oxford, L; Stone, TW; Stoy, N, 2006)
"Kynurenines were analysed by HPLC."1.33Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. ( Darlington, LG; Forrest, CM; Mackay, GM; Oxford, L; Stone, TW; Stoy, N, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forrest, CM1
Mackay, GM1
Oxford, L1
Stoy, N1
Stone, TW1
Darlington, LG1

Other Studies

1 other study available for anthranilic acid and Osteoporosis

ArticleYear
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
    Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:11

    Topics: 3-Hydroxyanthranilic Acid; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Indomethac

2006